E-DRUG: WHO Essential Drugs Committee meets this week
-----------------------------------------------------------
[Below is the agenda of the agenda of the 13th Expert Committee on the
Selection and Use of Essential Medicines, which started its meeting today
in Geneva. The meeting is until 3 April 2003.
See the agenda at
http://www.who.int/medicines/organization/par/edl/expcom13/expcom03agenda.s
html
From there you can download all proposals and technical documents.
The meeting itself is closed, apart for a short half day session this
morning.
Any e-drugger who was there can report what happened?
Feel free to open discussion on our open E-drug list!
WB]
13th Expert Committee on the Selection and Use of Essential Medicines, 31
March to 3 April 2003
Draft agenda (version, 24 March 2003)
Comments on the draft agenda items are welcomed, especially on the
applications for addition, change or deletion of medicines relating to the
Model List. Please contact:
The Secretary of the Expert Committee on the Selection and Use of Essential
Medicines
Policy, Acess and Rational Use
Essential Drugs and Medicines Policy
World Health Organization
20 Avenue Appia
CH-1211 Geneva 27
hogerzeilh@who.int
1. Update on current activities (19 March 2003)
Dissemination of Report of 12th Expert Committee
Report on 25th Anniversary of Model List of Essential Medicines
WHO Essential Medicines Library
WHO Model Formulary
Review of essential medicines for reproductive health
Review of New Emergency Health Kit
2. Applications for addition (21 March 2003)
Amodiaquine
Azithromycin
Ibuprofen paediatric formulation
Insulin semilente
Miconazole buccal tablet (re-application)
Misoprostol
Valaciclovir
3. Application for deletion (26 February 2003)
Ethinylestradiol + levonorgestrel tablet, 50�g + 250�g (pack of four)
Nonoxynol
4. Application for addition of information (21 January 2003)
Anti-leprosy medicines
5. Application for change (14 February 2003)
Levonorgestrel tablet, 1.5mg (additional dosage form)
Oral Rehydration Salts (change in formula)
Streptokinase (dosage modification)
6. Fast-track procedure for deletion (18 February 2003)
Description of method used
Proposals for fast-track deletion
Proposals for priority review
7. Review of Core and Complementary Listing (22 January 2003)
Description of method used; proposed definition
Proposals for change in core and/or complementary status
8. Review of use of Square Box Symbol (15 January 2003)
Description of method used
Proposals for deletion of square box symbol
Proposals for priority review
9. Review of section 12.3 Antihypertensive Medicines (24 March 2003)
Update on WHO Hypertension Guidelines
Proposals for addition, change and/or deletion
Magnesium sulphate as antihypertensive for treatment of pre-eclampsia
Calcium antagonists: message
10. Proposals for priority review for next meeting(s) (17 March 2003)
Analysis of the WHO Model List and 25 National Essential Drugs Lists
Grand total summary: drugs sorted by alphabetical order: occurrence in 25
National Drugs Lists
Grand total summary: drugs sorted by frequency: occurrence in 25 National
Drugs Lists
Spreadsheet 1: Additions and deletions to WHO Model List 1979-2002
Spreadsheet 2: Comparative analysis of WHO Lists 1977-2002
Spreadsheet 3: Grand total A summary 25 national lists
Spreadsheet 4: Grand total B summary 15 national lists
11. Review of activities to promote rational drug use (19 March 17 March
2003)
Update on activities to contain antimicrobial resistance
Guidelines for Drugs and Therapeutic Committees
WHO database on rational drug use
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: Essentialdrugs.org